Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • hklein
    Junior Member
    • Nov 2009
    • 4

    #1

    Bioinformatician (Core Facility) - Institute of Molecular Biology, Mainz - Germany

    The Institute of Molecular Biology gGmbH funded by the Boehringer Ingelheim Foundation

    is recruiting a Bioinformatician (m/f) (#CFBI06)

    The Institute of Molecular Biology gGmbH (IMB) is a Centre of Excellence for Life Sciences funded by the Boehringer Ingelheim Foundation, and located within the Johannes Gutenberg University in Mainz, Germany. The IMB focuses on epigenetics, DNA repair and developmental biology and offers state of the art core facilities covering genomics, cytometry, proteomics and microscopy, with bioinformatics / statistics connecting facilities and departments (http://www.imb-mainz.de/core-facilities/). We are looking for a Bioinformatician (m/f) to join the Core Facility.

    You will:
    • Analyse data generated by high throughput technologies, especially from next-generation sequencing
    • Consult scientists on the analysis of data, experimental planning, data validation and functional analysis
    • Collaborate with our scientists on several projects in parallel
    • Assess existing and develop new data analysis methods for high-throughput data
    • Develop and maintain data analysis pipelines and infrastructure
    • Train users in bioinformatics and statistics


    Required qualifications:
    • Formal training in a quantitative discipline (e.g. PhD, Diploma or equivalent in mathematics, physics, statistics, bioinformatics)
    • At least 3 years’ experience in the analysis of high-throughput genomics data
    • Sound knowledge of statistics and R/Bioconductor
    • In-depth programming skills, at least one language (Perl, Python, Java, C++,...) and familiarity with Linux/Unix
    • Experience in the design of robust analysis pipelines
    • Interest to acquire in-depth knowledge about biological processes
    • Proficiency in written and spoken English
    • Commitment and dedication to your work


    Desirable qualifications:
    • Successful interdisciplinary collaborations
    • Experience with computing clusters and bioinformatics workflow environments
    • Software engineering


    We offer:
    • Research in a competitive and dynamic international environment
    • Advanced training opportunities
    • Competitive salary
    • Favourable pension scheme



    IMB is an equal opportunity employer. Application deadline is September 15th 2013, and the successful applicant should start as soon as possible, with an initial contract for 2 years, incl. an option for extension. To apply, please email a single PDF including a cover letter, CV, certificates and contact information of three professional references quoting Ref. No. CFBI06 to [email protected]. Informal inquiries can be made to Dr Holger Klein ([email protected]).
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
72 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...